Log-in
Register now
Register now
Log-in

Nordic Life Science Days 2016
14-15 september 2016
Waterfront, Stockholm, Sweden

© 2019 Bionordic. All Rights Reserved

Register now
Log-in

Photo by Miklos Szabo

Register now
Log-in
Log-in

Latest news in cooperation with Nordic Life Science

News

Umeå Biotech Incubator to receive SEK 10 million research grant

26 August 2019 | 9:27 am
Jennie Ekbeck
Umeå Biotech Incubator (UBI) has been named the only incubator in the Nordic region to once again be granted funding from the prestigious Erling Persson Family Foundation. UBI is being granted SEK 10 million between 2020-2022 to help researchers commercialise their ideas for the greater benefit of society. It is the third time UBI has […]
News

Positive preclinical data from Cantargia

26 August 2019 | 9:21 am
cantargia-goran
The company has announced new positive preclinical data which defines a novel additional development opportunity for Cantargias antibody CAN04. The molecular target for CAN04, IL1RAP, has been detected on the cancer cells in approximately 80 % of patients with bladder cancer. Furthermore, a pronounced and statistically significant single agent activity was documented in an in […]
News

Altimmune announces $3.7 Million in Additional BARDA Funding

26 August 2019 | 9:17 am
US dollars
The Biomedical Advanced Research and Development Authority (BARDA) is modifying its existing anthrax vaccine development contract with Altimmune by awarding an additional $3.7 million. The increase in funding is primarily directed toward a Phase 1b clinical trial of NasoShield to evaluate alternative methods of intranasal dosing in humans. Phae Ib trial expected to start 2019 […]
News

Securities lawsuit filed in Denmark against Novo Nordisk

22 August 2019 | 8:20 am
Lars Fruergaard Joergensen
Novo Nordisk A/S has been informed that a securities lawsuit has been filed against the company in Denmark. The lawsuit is filed by a number of shareholders. The claim is for a total amount of DKK 11,785,192,218 ($1.75 billion) based on their trading and holding of shares in Novo Nordisk A/S during the period 3 […]
News

Sobi sells Priority Review Voucher to AstraZeneca

22 August 2019 | 8:11 am
Sobi Research
Swedish Orphan Biovitrum has entered into an agreement to sell a US Food and Drug Administration (FDA) Priority Review Voucher (PRV) to AstraZeneca for a total cash consideration of USD 95 million. A PRV entitles the holder to FDA priority review of a single New Drug Application or Biologics License Application, which reduces the target […]
News

Alligator signs agreement with Biotheus

22 August 2019 | 8:07 am
Alligator signs agreement with Biotheus
Alligator Bioscience has announced that a license agreement has been reached with Biotheus, a privately held Chinese company based in Zhuhai, Guangdong, China. Under the license agreement, Alligator has granted Biotheus rights in Greater China (including Republic of China, Hongkong, Taiwan and Macau) to an antibody from ALLIGATOR-GOLD for the creation of up to three […]
News

Cellink acquires the German company Cytena

22 August 2019 | 8:01 am
Cellink acquires the German company Cytena
The bioink company has entered an agreement with the owners of Cytena to acquire all its shares for a purchase price of 30.25M euros. Through cytena’s complementary technology offering, Cellink sees great synergies that will support future growth. About Cytena Cytena is a life science company focusing on single-cell technologies. It was founded in 2014 […]
News

LIDDS has appointed a new CFO

21 August 2019 | 5:19 am
LIDDS has appointed a new CFO
The company has appointed Anja Peters Ohlsson as new CFO of LIDDS AB and member of the management team. Anja will succeed Bengt Norvik, who will leave his position in September following many years as CFO of the company. Anja holds a Major in Accounting and Finance from Uppsala University. Previous positions include CFO of […]
News

Positive results from AstraZeneca trial

20 August 2019 | 2:16 pm
Mene Pangalos
The company has announced positive results from the landmark Phase III DAPA-HF trial which showed that Farxiga (dapagliflozin) met theprimary composite endpoint with a statistically-significant and clinically-meaningful reduction of cardiovascular death or the worsening of heart failure (defined as hospitalisation or an urgent heart failure visit), compared to placebo. The trial was conducted in patients […]
News

Researchers have discovered a new pain organ in the skin

19 August 2019 | 7:30 am
Researchers have discovered a new pain organ in the skin
Researchers at Karolinska Institutet in Sweden have discovered a new sensory receptor organ that is able to detect painful mechanical damage, such as pricks and impacts. Pain causes suffering and results in substantial costs for society. Almost one person in every five experiences constant pain and there is a considerable need to find new painkilling […]

© 2019 Bionordic. All Rights Reserved

Legal Notices

© 2019 Bionordic. All Rights Reserved

Legal Notices